As Chief Executive Officer of Mercalis, Scott is a life sciences commercialization champion who is driven by the company’s underlying mission of enhancing patients’ lives. Since joining Mercalis in 2015, Scott has led the transformation of the company from a market-leading patient affordability provider to a fully integrated commercialization services partner for the life sciences industry. Under Scott’s leadership, the company has experienced a combination of robust organic growth and purposeful inorganic expansion (e.g. seven acquisitions since 2018). The growth strategy Scott architected has resulted in a unique blend of technology capabilities and industry insights that help clients navigate complexity and accelerate value. In his previous role as President and Chief Strategy Officer for Mercalis, Scott led corporate development and strategy, mergers and acquisitions (M&A), finance, IT, and legal/compliance.

Before joining Mercalis in 2015, Scott worked for Taiho Oncology, where he led several market access functions including the strategic design and implementation of a limited specialty pharmacy network and patient support program for an oral oncology product. Scott has also held general manager and senior leadership positions in operations, strategy and product development, IT, and enterprise sales with United BioSource Corporation (UBC), an Express Scripts company, and AccessMED, a McKesson Specialty and U.S. Oncology company.

Scott holds a Bachelor of Business Administration degree with a major in Management Information Systems from Iowa State University and an MBA with an emphasis in finance from the University of Kansas. He and his wife, Lisa, and their two children reside in Shawnee, KS. In his spare time, Scott enjoys exercising, traveling the country with his family, and boating at the Lake of the Ozarks.